JYHZ2500033 | 盐酸罗匹尼罗缓释片 | ropinirole hydrochloride | Tablet, extended release | Chemical Drugs | License Renew | 2025-02-22 | | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Wellcome SA;GlaxoSmithKline SA | | | view |
JYHZ2500034 | 盐酸罗匹尼罗缓释片 | ropinirole hydrochloride | Tablet, extended release | Chemical Drugs | License Renew | 2025-02-22 | | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Wellcome SA;GlaxoSmithKline SA | | | view |
CYHB2400824 | 盐酸罗匹尼罗缓释片 | ropinirole hydrochloride | Tablet, extended release | Chemical Drugs(4) | Supplementary Application | 2024-06-14 | | Nanjing Hencer Pharmaceutical Co Ltd | | | view |
CYHS2400315 | 盐酸罗匹尼罗缓释片 | ropinirole hydrochloride | Tablet, extended release | Chemical Drugs(4) | Generic Drug | 2024-01-24 | | Zein BIOTECHNOLOGY Co Ltd | | | view |
CYHS2400314 | 盐酸罗匹尼罗缓释片 | ropinirole hydrochloride | Tablet, extended release | Chemical Drugs(4) | Generic Drug | 2024-01-24 | | Zein BIOTECHNOLOGY Co Ltd | | | view |
CYHS2301805 | 盐酸罗匹尼罗缓释片 | ropinirole hydrochloride | Tablet, extended release | Chemical Drugs(4) | Generic Drug | 2023-07-05 | | Hangzhou Hezekunyuan Pharmaceutical Co Ltd;Guangzhou Bositao Controlled Release Pharmaceutical Co Ltd | | | view |
CYHS2301463 | 盐酸罗匹尼罗缓释片 | ropinirole hydrochloride | Tablet, extended release | Chemical Drugs(4) | Generic Drug | 2023-05-31 | | Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Co Ltd;Nanjing Hencer Pharmaceutical Co Ltd | | | view |
CYHS2301464 | 盐酸罗匹尼罗缓释片 | ropinirole hydrochloride | Tablet, extended release | Chemical Drugs(4) | Generic Drug | 2023-05-31 | | Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Co Ltd;Nanjing Hencer Pharmaceutical Co Ltd | | | view |
JYHB2101568 | 盐酸罗匹尼罗缓释片 | ropinirole hydrochloride | Tablet, extended release | Chemical Drugs | Supplementary Application | 2021-12-07 | | Glaxo Wellcome SA;GlaxoSmithKline SA | | | view |
JYHB2101567 | 盐酸罗匹尼罗缓释片 | ropinirole hydrochloride | Tablet, extended release | Chemical Drugs | Supplementary Application | 2021-12-07 | | Glaxo Wellcome SA;GlaxoSmithKline SA | | | view |
JYHB2100122 | 盐酸罗匹尼罗缓释片 | ropinirole hydrochloride | Tablet, extended release | Chemical Drugs | Supplementary Application | 2021-02-05 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Wellcome SA;GlaxoSmithKline SA | In Review | 2021-02-05 | view |
JYHB2100121 | 盐酸罗匹尼罗缓释片 | ropinirole hydrochloride | Tablet, extended release | Chemical Drugs | Supplementary Application | 2021-02-05 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Wellcome SA;GlaxoSmithKline SA | In Review | 2021-02-05 | view |
JYHB2100120 | 盐酸罗匹尼罗缓释片 | ropinirole hydrochloride | Tablet, extended release | Chemical Drugs | Supplementary Application | 2021-02-05 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Wellcome SA;GlaxoSmithKline SA | In Review | 2021-02-05 | view |
JYHB2002348 | 盐酸罗匹尼罗缓释片 | ropinirole hydrochloride | Tablet, extended release | Chemical Drugs | Supplementary Application | 2020-11-21 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Wellcome SA;GlaxoSmithKline SA | Filed | 2020-12-02 | view |
JYHB2002350 | 盐酸罗匹尼罗缓释片 | ropinirole hydrochloride | Tablet, extended release | Chemical Drugs | Supplementary Application | 2020-11-21 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Wellcome SA;GlaxoSmithKline SA | Filed | 2020-12-02 | view |
JYHB2002349 | 盐酸罗匹尼罗缓释片 | ropinirole hydrochloride | Tablet, extended release | Chemical Drugs | Supplementary Application | 2020-11-21 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Wellcome SA;GlaxoSmithKline SA | Filed | 2020-12-02 | view |
JYHB2001613 | 盐酸罗匹尼罗缓释片 | ropinirole hydrochloride | Tablet, extended release | Chemical Drugs | Supplementary Application | 2020-08-28 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Wellcome SA;GlaxoSmithKline SA | Filed | 2020-09-11 | view |
JYHB2001612 | 盐酸罗匹尼罗缓释片 | ropinirole hydrochloride | Tablet, extended release | Chemical Drugs | Supplementary Application | 2020-08-28 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Wellcome SA;GlaxoSmithKline SA | Filed | 2020-09-11 | view |
JYHB2001611 | 盐酸罗匹尼罗缓释片 | ropinirole hydrochloride | Tablet, extended release | Chemical Drugs | Supplementary Application | 2020-08-28 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Wellcome SA;GlaxoSmithKline SA | Filed | 2020-09-11 | view |
JYHZ2000031 | 盐酸罗匹尼罗缓释片 | ropinirole hydrochloride | Tablet, extended release | Chemical Drugs | License Renew | 2020-03-16 | | Glaxo Wellcome SA | Certificate Issued | 2020-08-20 | view |